Enhanced pregnancy outcomes with intrauterine platelet-rich plasma infusion in women following failed personalized embryo transfer guided by endometrial receptivity assay
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250359Keywords:
Platelet rich plasma, ERA, Recurrent implantation failure, Endometrial receptivity, FETAbstract
Background: Altered endometrial receptivity is an important cause of implantation failure. The embryo-endometrial asynchrony due to ovarian stimulation in IVF cycles contributes to low success rates. Frozen embryo transfer (FET) has become popular a method to overcome this asynchrony. Endometrial receptivity array (ERA) is a molecular test that differentiates a receptive from a non-receptive endometrium. Studies suggest that a personalised embryo transfer (pET) guided by ERA in FET cycles, improves pregnancy rates in recurrent implantation failure (RIF) patients. Despite pET not all patients achieve implantation. Intrauterine infusion of platelet-rich plasma (IUPRP) is emerging as an innovative technique to enhance fertility outcomes in patients with impaired endometrial receptivity. Platelet rich plasma (PRP) contains an abundance of growth factors and cytokines thought to enhance endometrial growth and receptivity. Aim of the study was to evaluate the role of IUPRP in improving pregnancy rate in patients with failed pET.
Methods: 53 patients with two previous pET failures, having an endometrial thickness ≥7 mm were included in this observational cohort study. FET was planned in a hormone replacement cycle. 0.4 ml PRP prepared by double centrifugation technique was infused into the uterus on the day of starting progesterone.
Results: A pregnancy rate of 64.1% and Live birth rate of 49.06% was achieved at FET after IUPRP infusion. Miscarriage rate was 17.6%. These results are similar to pregnancy and live birth rates achieved in our non-RIF IVF patients.
Conclusions: Our study suggests an improved reproductive outcome with infusion of IUPRP in patients with who failed to implant after pET.
Metrics
References
Hernández-Vargas P, Muñoz M, Domínguez F. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes. Human Reprod Update. 2020;26(2):264-301. DOI: https://doi.org/10.1093/humupd/dmz042
Okada H, Tsuzuki T, Murata H. Decidualization of the human endometrium. Reprod Med Biol. 2018;17(3):220-7. DOI: https://doi.org/10.1002/rmb2.12088
Lessey BA, Young SL. What exactly is endometrial receptivity? Fertil Steril. 2019;111(4):611-7. DOI: https://doi.org/10.1016/j.fertnstert.2019.02.009
Craciunas L, Gallos I, Chu J, Bourne T, Quenby S, Brosens JJ, Coomarasamy A. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Human Reprod Update. 2019;25(2):202-23. DOI: https://doi.org/10.1093/humupd/dmy044
Iwasa T, Kuwahara A, Takeshita T, Taniguchi Y, Mikami M, Irahara M. Preimplantation genetic testing for aneuploidy and chromosomal structural rearrangement: a summary of a nationwide study by the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2023;22(1):e12518. DOI: https://doi.org/10.1002/rmb2.12518
Tan J, Kan A, Hitkari J, Taylor B, Tallon N, Warraich G, et al. The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers. J Assisted Reprod Genetics. 2018;35:683-92. DOI: https://doi.org/10.1007/s10815-017-1112-2
Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50-60. DOI: https://doi.org/10.1016/j.fertnstert.2010.04.063
Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, Carranza F, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013;100(3):818-24. DOI: https://doi.org/10.1016/j.fertnstert.2013.05.004
Mahajan N. Endometrial receptivity array: clinical application. J Hum Reprod Sci. 2015;8:121-9. DOI: https://doi.org/10.4103/0974-1208.165153
Ben Rafael Z. Endometrial Receptivity Analysis (ERA) test: an unproven technology. Hum Reprod Open. 2021;2021(2):hoab010. DOI: https://doi.org/10.1093/hropen/hoab010
Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015;8(1):1286.
Coksuer H, Akdemir Y, Ulas Barut M. Improved in vitro fertilization success and pregnancy outcome with autologous platelet-rich plasma treatment in unexplained infertility patients that had repeated implantation failure history. Gynecol Endocrinol. 2019;35(9):815-8. DOI: https://doi.org/10.1080/09513590.2019.1597344
Maleki-Hajiagha A, Razavi M, Rouholamin S, Rezaeinejad M, Maroufizadeh S, Sepidarkish M. Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction: A systematic review and meta-analysis. J Reprod Immunol. 2020;137:103078. DOI: https://doi.org/10.1016/j.jri.2019.103078
Lin Y, Qi J, Sun Y. Platelet-rich plasma as a potential new strategy in the endometrium treatment in assisted reproductive technology. Front Endocrinol. 2021;12:707584. DOI: https://doi.org/10.3389/fendo.2021.707584
Deng H, Wang S, Li Z, Xiao L, Ma L. Effect of intrauterine infusion of platelet-rich plasma for women with recurrent implantation failure: A systematic review and meta-analysis. J Obstet Gynaecol. 2023;43(1):2144177. DOI: https://doi.org/10.1080/01443615.2022.2144177
Kim MK, Song H, Lyu SW, Lee WS. Platelet-rich plasma treatment in patients with refractory thin endometrium and recurrent implantation failure: A comprehensive review. Clin Exp Reprod Med. 2022;49(3):168. DOI: https://doi.org/10.5653/cerm.2022.05407
Russell SJ, Kwok YS, Nguyen TT, Librach C. Autologous platelet-rich plasma improves the endometrial thickness and live birth rate in patients with recurrent implantation failure and thin endometrium. J Assisted Reprod Genet. 2022;39(6):1305-12. DOI: https://doi.org/10.1007/s10815-022-02505-0
Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, et al. Uterine selection of human embryos at implantation. Sci Rep. 2014;4:3894. DOI: https://doi.org/10.1038/srep03894
Almohammadi A, Choucair F, El Taha L, Burjaq H, Albader M, Cavanillas AB, et al. The reproductive potential of vitrified-warmed euploid embryos declines following repeated uterine transfers. Reprod Biol Endocrinol. 2024;22(1):23. DOI: https://doi.org/10.1186/s12958-024-01192-z
Segal TR, Kim K, Mumford SL, Goldfarb JM, Weinerman RS. How much does the uterus matter? Perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients. Fertil Steril. 2018;110(5):888-95. DOI: https://doi.org/10.1016/j.fertnstert.2018.06.015
Sato T, Sugiura-Ogasawara M, Ozawa F, Yamamoto T, Kato T, Kurahashi H, et al. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum Reprod. 2019;34(12):2340-8. DOI: https://doi.org/10.1093/humrep/dez229
Liu KE, Hartman M, Hartman A, Luo ZC, Mahutte N. The impact of a thin endometrial lining on fresh and frozen-thaw IVF out-comes: an analysis of over 40000 embryo transfers. Hum Reprod. 2018;33(10):1883-8. DOI: https://doi.org/10.1093/humrep/dey281
Kumbak B, Erden HF, Tosun S, Akbas H, Ulug U, Bahçeci M. Outcome of assisted reproduction treatment in patients with endometrial thickness less than 7 mm. Reprod Biomed Online. 2009;18(1):79-84. DOI: https://doi.org/10.1016/S1472-6483(10)60428-2
Horgan RP, Clancy OH, Myers JE, Baker PN. An overview of proteomic and metabolomic technologies and their application to pregnancy research. Int J Obstet Gynaecol. 2009;116(2):173-81. DOI: https://doi.org/10.1111/j.1471-0528.2008.01997.x
Busnelli A, Somigliana E, Cirillo F, Baggiani A, Levi-Setti PE. Efficacy of therapies and interventions for repeated embryo implantation failure: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1747. DOI: https://doi.org/10.1038/s41598-021-81439-6
Tang R, Xiao X, He Y, Qiu D, Zhang W, Wang X. Clinical evaluation of autologous platelet-rich. plasma therapy for intrauterine adhesions: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1183209. DOI: https://doi.org/10.3389/fendo.2023.1183209
Huang HS, Chang HH. Platelets in inflammation and immune modulations: functions beyond hemostasis. Archivum Immunologiae et Therapiae Experimentalis. 2012;60:443-51. DOI: https://doi.org/10.1007/s00005-012-0193-y
Sak ME, Gul T, Evsen MS, Soydinc HE, Sak S, Ozler A, et al. Fibroblast growth factor-1 expression in the endometrium of patients with repeated implantation failure after in vitro fertilization. Eur Rev Med Pharmacol Sci. 2013;17(3):398-402.
Kuroda K, Matsumoto A, Horikawa T, Takamizawa S, Ochiai A, Kawamura K, et al. Transcriptomic profiling analysis of human endometrial stromal cells treated with autologous platelet‐rich plasma. Reprod Med Biol. 2023;22(1):e12498. DOI: https://doi.org/10.1002/rmb2.12498
Noushin MA, Ashraf M, Thunga C, Singh S, Singh S, Basheer R, et al. A comparative evaluation of subendometrial and intrauterine platelet-rich plasma treatment for women with recurrent implantation failure. F&S Sci. 2021;2(3):295-302. DOI: https://doi.org/10.1016/j.xfss.2021.03.002
Maged AM, El-Mazny A, Kamal N, Mahmoud SI, Fouad M, El-Nassery N, et al. The value of platelet-rich plasma in women with previous implantation failure: A systematic review and meta-analysis. J Assisted Reprod Genet. 2023;40(5):969-83. DOI: https://doi.org/10.1007/s10815-023-02781-4
Downloads
Published
How to Cite
Issue
Section
